Metabolic side effects of antipsychotic medications: Clinical laboratory implications

Thomas E. Hansen; Kristen Snyder; Erik Messamore; William F. Hoffman

doi:10.1309/X63H9LHUFFJJL6FH

Metabolic side effects of antipsychotic medications: Clinical laboratory implications

Thomas E. Hansen, Kristen Snyder, Erik Messamore, William F. Hoffman

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Abstract

Atypical antipsychotic medications can cause weight gain, hyperglycemia, dyslipidemia, and hyperprolactinemia. Clinical laboratories should expect that with increasing prescription of these medications, monitoring of fasting blood sugar, hemoglobin A 1 c, and blood lipid levels should also increase.

Original language	English (US)
Pages (from-to)	625-627
Number of pages	3
Journal	Laboratory Medicine
Volume	35
Issue number	10
DOIs	https://doi.org/10.1309/X63H9LHUFFJJL6FH
State	Published - Oct 2004

ASJC Scopus subject areas

Clinical Biochemistry
Biochemistry, medical

Access to Document

10.1309/X63H9LHUFFJJL6FH

Cite this

@article{92ff1353ec7141069aa2c40f2da0a500,

title = "Metabolic side effects of antipsychotic medications: Clinical laboratory implications",

abstract = "Atypical antipsychotic medications can cause weight gain, hyperglycemia, dyslipidemia, and hyperprolactinemia. Clinical laboratories should expect that with increasing prescription of these medications, monitoring of fasting blood sugar, hemoglobin A 1 c, and blood lipid levels should also increase.",

author = "Hansen, {Thomas E.} and Kristen Snyder and Erik Messamore and Hoffman, {William F.}",

year = "2004",

month = oct,

doi = "10.1309/X63H9LHUFFJJL6FH",

language = "English (US)",

volume = "35",

pages = "625--627",

journal = "Laboratory Medicine",

issn = "0007-5027",

publisher = "American Society of Clinical Pathologists",

number = "10",

}

TY - JOUR

T1 - Metabolic side effects of antipsychotic medications

T2 - Clinical laboratory implications

AU - Hansen, Thomas E.

AU - Snyder, Kristen

AU - Messamore, Erik

AU - Hoffman, William F.

PY - 2004/10

Y1 - 2004/10

N2 - Atypical antipsychotic medications can cause weight gain, hyperglycemia, dyslipidemia, and hyperprolactinemia. Clinical laboratories should expect that with increasing prescription of these medications, monitoring of fasting blood sugar, hemoglobin A 1 c, and blood lipid levels should also increase.

AB - Atypical antipsychotic medications can cause weight gain, hyperglycemia, dyslipidemia, and hyperprolactinemia. Clinical laboratories should expect that with increasing prescription of these medications, monitoring of fasting blood sugar, hemoglobin A 1 c, and blood lipid levels should also increase.

UR - http://www.scopus.com/inward/record.url?scp=4644271597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644271597&partnerID=8YFLogxK

U2 - 10.1309/X63H9LHUFFJJL6FH

DO - 10.1309/X63H9LHUFFJJL6FH

M3 - Review article

AN - SCOPUS:4644271597

SN - 0007-5027

VL - 35

SP - 625

EP - 627

JO - Laboratory Medicine

JF - Laboratory Medicine

IS - 10

ER -

Metabolic side effects of antipsychotic medications: Clinical laboratory implications

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this